Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pax transactivation domain-interacting protein is required for preserving hematopoietic stem cell quiescence via regulating lysosomal activityHaematologica (Roma), 2023-09, Vol.108 (9), p.2410-2421 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282224 ;PMID: 36924252Full text available |
|
2 |
Material Type: Article
|
Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasmsHaematologica (Roma), 2023-09, Vol.108 (9), p.2271-2272 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.282998 ;PMID: 37078265Full text available |
|
3 |
Material Type: Article
|
Prognostic tools for older patients with diffuse large B-cell lymphoma: complex patients require complex solutions and a personal touchHaematologica (Roma), 2023-09, Vol.108 (9), p.2269-2270 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283000 ;PMID: 36994499Full text available |
|
4 |
Material Type: Article
|
New patterns of genetic instability in chronic myeloid leukemia: interesting, but not ready for clinical useHaematologica (Roma), 2023-09, Vol.108 (9), p.2273-2274 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283059 ;PMID: 37078263Full text available |
|
5 |
Material Type: Article
|
Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic modelHaematologica (Roma), 2023-09, Vol.108 (9), p.2558-2558 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283685 ;PMID: 37317924Full text available |
|
6 |
Material Type: Article
|
Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?Haematologica (Roma), 2023-09, Vol.108 (9), p.2267-2268 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.282893 ;PMID: 37199128Full text available |
|
7 |
Material Type: Article
|
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023Haematologica (Roma), 2023-03, Vol.108 (9), p.2275-2288 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.281106 ;PMID: 36861399Full text available |
|
8 |
Material Type: Article
|
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)Haematologica (Roma), 2023-09, Vol.108 (9), p.2331-2342 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282030 ;PMID: 36951163Full text available |
|
9 |
Material Type: Article
|
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicityHaematologica (Roma), 2023-09, Vol.108 (9), p.2343-2357 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.281894 ;PMID: 37021547Full text available |
|
10 |
Material Type: Article
|
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survivalHaematologica (Roma), 2023-09, Vol.108 (9), p.2542-2545 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282627 ;PMID: 36794509Full text available |
|
11 |
Material Type: Article
|
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapyHaematologica (Roma), 2023-09, Vol.108 (9), p.2454-2466 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282289 ;PMID: 36861406Full text available |
|
12 |
Material Type: Article
|
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic miceHaematologica (Roma), 2023-09, Vol.108 (9), p.2535-2541 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282614 ;PMID: 36794508Full text available |
|
13 |
Material Type: Article
|
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTHaematologica (Roma), 2023-09, Vol.108 (9), p.2305-2315 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.281876 ;PMID: 36951165Full text available |
|
14 |
Material Type: Article
|
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patientsHaematologica (Roma), 2023-09, Vol.108 (9), p.2531-2534 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282596 ;PMID: 36794507Full text available |
|
15 |
Material Type: Article
|
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemiaHaematologica (Roma), 2023-09, Vol.108 (9), p.2396-2409 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282140 ;PMID: 37021528Full text available |
|
16 |
Material Type: Article
|
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionHaematologica (Roma), 2023-09, Vol.108 (9), p.2380-2395 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282184 ;PMID: 36951160Full text available |
|
17 |
Material Type: Article
|
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG databaseHaematologica (Roma), 2023-09, Vol.108 (9), p.2467-2475 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.281847 ;PMID: 36951150Full text available |
|
18 |
Material Type: Article
|
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma AllianceHaematologica (Roma), 2023-09, Vol.108 (9), p.2444-2453 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.281375 ;PMID: 36815381Full text available |
|
19 |
Material Type: Article
|
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceHaematologica (Roma), 2023-09, Vol.108 (9), p.2369-2379 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.282729 ;PMID: 36951151Full text available |
|
20 |
Material Type: Article
|
Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cellsHaematologica (Roma), 2023-09, Vol.108 (9), p.2422-2434 [Peer Reviewed Journal]Copyright© 2023 Ferrata Storti Foundation ;ISSN: 0390-6078 ;ISSN: 1592-8721 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2022.282638 ;PMID: 36924254Full text available |